Followers | 72 |
Posts | 4228 |
Boards Moderated | 2 |
Alias Born | 08/21/2015 |
Thursday, May 13, 2021 10:05:03 AM
Director Of Manufacturing, Inhalation Product Development at AstraZeneca
Chapel Hill, North Carolina, United States 500+ connections
https://www.linkedin.com/in/peter-mack-5877314/
Experience
AstraZeneca
Company NameAstraZeneca
Total Duration4 yrs 1 mo
TitleDirector Of Manufacturing, Inhalation Product Development
Dates EmployedJan 2020 – Present
Employment Duration1 yr 5 mos
LocationRTP, NC
TitleGlobal Pharmaceutical Project Director, Respiratory
Dates EmployedMay 2017 – Jan 2020
Employment Duration2 yrs 9 mos
LocationRTP, NC
Pearl Therapeutics, an AstraZeneca group company
Company NamePearl Therapeutics, an AstraZeneca group company
Total Duration4 yrs 3 mos
TitleAssociate Director, Inhalation Product Development
Dates EmployedSep 2014 – May 2017
Employment Duration2 yrs 9 mos
LocationRTP, NC
TitleSenior Scientist
Dates EmployedMar 2013 – Aug 2014
Employment Duration1 yr 6 mos
Liquidia Technologies
Company NameLiquidia Technologies
Total Duration4 yrs 4 mos
TitlePrincipal Scientist
Dates EmployedJan 2012 – Mar 2013
Employment Duration1 yr 3 mos
TitleSenior Scientist
Dates EmployedJan 2010 – Feb 2012
Employment Duration2 yrs 2 mos
Show 1 more role
Brigham and Women's Hospital
Post-doctoral research associate
Company NameBrigham and Women's Hospital
Dates EmployedSep 2008 – Nov 2008
Employment Duration3 mos
Harvard Medical School
Graduate Student
Company NameHarvard Medical School
Dates EmployedFeb 2006 – Aug 2008
Employment Duration2 yrs 7 mos
Cardiovascular biomechanics, pathophysiology, and tissue engineering; High-throughput screening
Graduate Student
Company NameMIT
Dates EmployedAug 2004 – Aug 2008
Employment Duration4 yrs 1 mo
Cardiovascular biomechanics, pathophysiology, and tissue engineering
NP Medical Inc
Engineering Consultant
Company NameNP Medical Inc
Dates EmployedJan 2007 – Mar 2007
Employment Duration3 mos
Fluid dynamic consultant for IV drug delivery systems
Education
Harvard Medical School
Harvard Medical School
Degree NamePhDField Of StudyMedical Engineering
Dates attended or expected graduation2004 – 2008
Activities and Societies: Admissions Committee Member
NIH Biomechanics Training Grant Recipient
Massachusetts Institute of Technology
Massachusetts Institute of Technology
Degree NameMS/PhDField Of StudyMedical Engineering
Dates attended or expected graduation2002 – 2008
Activities and Societies: Public Service Center and Service Learning Center Fellow
NIH Biomechanics Training Grant Recipient
University of Notre Dame
University of Notre Dame
Degree NameBSField Of StudyMechanical Engineering
Dates attended or expected graduation1998 – 2002
Recent MNMD News
- MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York • Business Wire • 05/04/2024 12:00:00 PM
- MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update • Business Wire • 05/02/2024 11:00:00 AM
- MindMed to Present at Upcoming May Medical Conferences • Business Wire • 04/25/2024 11:00:00 AM
- MindMed to Present at Upcoming April Medical Conferences • Business Wire • 04/02/2024 11:00:00 AM
- MindMed Announces Voluntary Delisting from Cboe Canada • Business Wire • 04/01/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:32:03 PM
- MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference • Business Wire • 03/11/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:19:43 PM
- Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement • Business Wire • 03/07/2024 12:13:00 PM
- Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)] • Edgar (US Regulatory) • 03/07/2024 12:09:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:56:00 AM
- MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder • Business Wire • 03/07/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 06:56:37 PM
- MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120 • Business Wire • 03/01/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 12:20:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:15:11 PM
- MindMed Reports 2023 Financial Results and Business Updates • Business Wire • 02/28/2024 12:05:00 PM
- MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update • Business Wire • 02/22/2024 12:00:00 PM
- MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference • Business Wire • 02/07/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:00:24 PM
- MindMed Announces Business Update and Anticipated Milestones for 2024 • Business Wire • 01/08/2024 12:45:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM